01 1Emcure Pharmaceuticals
01 1RITONAVIR USP (PROCESS II)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-02
Pay. Date : 2013-09-18
DMF Number : 26463
Submission : 2012-10-06
Status : Active
Type : II
20
Emcure Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RITONAVIR USP (PROCESS II), with a corresponding US DMF Number 26463.
Remarkably, this DMF maintains an Active status since its submission on October 06, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 02, 2014, and payment made on September 18, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
